Table 1.
Non-pharmacologic | Mechanism | Benefit |
---|---|---|
Patient education | De-stigmatization, understanding symptoms, avoiding triggers, protection when experiencing symptoms | Allows patients to attain access to therapy; allows patients to be self-advocates of their own health2,42 |
Avoidance of symptom exacerbating medications | Avoid medications that reduce blood volume and/or decrease blood vessel tone Avoid norepinephrine reuptake inhibitors |
Decrease risk of exacerbating orthostatic tachycardia or orthostatic symptoms8,43 Decrease symptom burden and risk of increased standing HR44 |
Management of comorbid conditions | Complex multiple mechanisms | Holistic approach to the management of POTS to decrease symptoms burden |
Oral rehydration and salt supplementation | Increases CBFV and promotes volume expansion via fluid and salt absorption | Increases orthostatic tolerance and mitigates autonomic symptoms40 |
Physical activities | Physical conditioning via increases VO2peak and peak stroke volume/cardiac output | Improves quality of life; decreases tachycardia related symptom burden45-47 |
Head-up (supine) sleep positioning | Conditions the heart by activation of the RAAS and increasing total blood volume | Improves orthostatic tolerance and overall syncope burden48 |
Compression garments | Shifts pooled blood in lower extremities back into central circulation to increase cardiac output | Reduces tachycardia and symptom burden49 |
CBFV , cerebral blood flow velocity; POTS, postural orthostatic tachycardia syndrome; RAAS, renin-angiotensin-aldosterone-system; VO2peak , peak oxygen uptake